Biosyent Inc (BIOYF) 6.3800 $BIOYF BioSyent Comments on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biosyent Inc (BIOYF) 6.3800 $BIOYF

BioSyent Comments on Recent Market Activity
Marketwired - Fri Apr 10, 7:01AM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) wishes to comment on the unusual recent market activity in its stock. The Company advises that it is not aware of any material undisclosed business development that should account for the decrease in its stock price on Thursday, April 9, 2015. The Company looks forward to disclosing its first quarter results on May 13, 2015.
RX.VN: 8.130 (+0.720)

BioSyent Pharma Announces the Canadian Launch of the First of 3 New Products Using the Patented Aguettant System(R)
Marketwired - Tue Feb 03, 7:05AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of the Aguettant System(R) for pre-filled syringes (PFS), a new urgent care product for use in hospitals and acute care settings.
RX.VN: 8.130 (+0.720)

BioSyent Pharma Launches New Proktis-M(R) Suppositories
Marketwired - Mon Nov 24, 7:07AM CST
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of Proktis-M(R) suppositories.
RX.VN: 8.130 (+0.720)

BioSyent Releases Q3 and Nine Month Results-Q3 Sales Increase 56%, Net Income Up 64%; Nine Month Sales Up 62%, Net Income Up 75%
Marketwired - Mon Oct 20, 7:06AM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) released today a summary of its Third Quarter (Q3 2014) and nine months financial results for the three and nine months ending September 30, 2014. Key highlights include:
RX.VN: 8.130 (+0.720)

BioSyent Releases Q2 and Six Month Results-Q2 Sales Increase 72%, Net Income After Tax Up 112%
Marketwire - Thu Aug 21, 7:03AM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) released today a summary of its Second Quarter (Q2 2014) and first half (H1 2014) financial results for the three and six months ending June 30, 2014. Key highlights include:
RX.VN: 8.130 (+0.720)

BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For New Urgent Care Drug Product
Marketwire - Wed Jul 23, 8:44AM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive Licensing and Distribution Agreement with an existing European partner for a new product that will be marketed by its' Hospital Products Division. The new product utilizes a patented delivery system that offers technical advantages over existing alternatives and will be used in hospitals and acute care settings. These products will provide hospitals, clinics, and healthcare professionals with improved patient safety as well as operational efficiencies. The product will be launched after Health Canada approval.
RX.VN: 8.130 (+0.720)

BioSyent Inc. (TSXV:RX) is the Subject of StockPotentials Report by eResearch Corp - Video Summary of Report Posted on www.investmentpitch.com
Thomson Reuters ONE - Mon Jul 07, 6:28PM CDT
Vancouver, BC, July 7, 2014 - Toronto based eResearch has issued a StockPotentials report on BioSyent Inc. (TSXV:RX), a Toronto-based, growth oriented, independent pharmaceutical company. StockPotentials reports cover smaller companies eResearch believes would be primarily of interest to retail investors.
RX.VN: 8.130 (+0.720)

eResearch Issues Stock Potentials Report on BioSyent Inc.
ACCESSWIRE - Thu Jul 03, 10:51AM CDT
Toronto, ON / ACCESSWIRE / July 3, 2014 / eResearch Corporation provides Stock Potentials reports to highlight interesting prospects which may benefit from the exposure that eResearch can provide through its extensive electronic distribution network. This latest report features BioSyent Inc., a growth-oriented specialty pharmaceutical company, based in Toronto.
RX.VN: 8.130 (+0.720)

BioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
Marketwire - Fri Jun 13, 4:13PM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) is pleased to announce that CEO Rene Goehrum will be making a presentation at the 2014 Bloom Burton & Co. Healthcare Investor Conference at 4:30pm (ET), June 18, 2014 at the Toronto Board of Trade. Mr. Goehrum will provide an overview of the Company and its corporate activities.
RX.VN: 8.130 (+0.720)

BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608%
Marketwire - Thu Jun 12, 3:02PM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) is pleased to announce that Canadian Business and PROFIT has ranked BioSyent as one of Canada's Fastest-Growing Companies in the just released 2014 rankings. Published in the July issue of Canadian Business and online at PROFITguide.com, the PROFIT 500 ranks Canadian businesses by their revenue growth over five years. Based upon a five year revenue (2008-2013) growth rate of 608%, BioSyent ranked 104 on the PROFIT 500 list. This is the second consecutive year that BioSyent has been named to the Profit 500 list and marks a significant increase in 5 year growth rate, from 355% on last year's list to 608% on this year's list.
RX.VN: 8.130 (+0.720)

BioSyent Pharma Receives Health Canada Approval to Market New Urgent Care Product
Marketwire - Thu Jun 12, 7:03AM CDT
BioSyent Inc. ("BioSyent" (TSX VENTURE: RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has received Health Canada - Therapeutics Products Directorate approval to market a new urgent care product. This is the first of two products that were in-licensed from a European partner and submitted to Health Canada in 2013 for approval.
RX.VN: 8.130 (+0.720)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Xi Jinping Thought: A Bold Prospect for Future Governance

Updated Category News Views 5

107 years in the game, and the Communist Party of China (CPC) isn't showing any signs of slowing. With their recent conference in Beijing focusing on Xi Jinping Thought on Party Building, it’s clear they’ve got their eyes on the future, not just resting on past laurels. This Xi Jinping Thought is about a thorough self-improvement plan for the Party, a clear strategy...

Continue Reading
GAC's Cambodia Plant: A Strategic Manufacturing Shift

Updated Category News Views 3

Setting the Stage for New Industrial Growth On September 17, a milestone was etched in the sands of Cambodia when the GAC Cambodia KD Plant officially flipped the switch. This ain't just another factory throwing doors open; it's a fresh chapter in regional manufacturing power plays. We had some big hitters in attendance, like Cambodian Prime Minister Hun Manet, showing...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 4

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
USPS Rolls Out Christmas Cookie Stamps Nationwide

Updated Category News Views 5

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 5

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 5

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
Fast Guard Elevates Nationwide Fire Watch Mission

Updated Category News Views 2

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Continue Reading
Quay Dominates 2026 Sunglasses Review for Variety

Updated Category News Views 4

Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...

Continue Reading
China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 4

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading
Chery Auto's Bold Green Tech Showcase at 2026 Summit

Updated Category News Views 3

Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...

Continue Reading

Top 5 Most Recently Viewed Articles

BingX AI Enhances Trading Efficiency with Comprehensive Analysis

Updated Category News Views 123

Unlocking Intelligent Trading with BingX AI BingX, a prominent cryptocurrency exchange and Web3 AI company, has made significant advancements with its innovative BingX AI features. Designed to meet the actual needs of users, this intelligent system simplifies complex trading decisions, making it an indispensable tool for those navigating the cryptocurrency markets....

Continue Reading
Key Developments in Tech: Nvidia, Apple, and Meta Shining Bright

Updated Category News Views 442

Exciting Developments in the Tech Industry The tech landscape has been abuzz with notable events that shaped the industry recently. Significant actions by government and corporations alike are setting the stage for what’s to come. With high-profile moves from powerhouses like Nvidia and Apple, the implications for consumers and businesses alike are substantial. Nvidia...

Continue Reading
Visa Inc. Faces Class Action Lawsuit Over Alleged Misconduct

Updated Category News Views 331

Visa Inc. Under Fire: Class Action Lawsuit Overview The financial landscape is witnessing significant developments as Pomerantz LLP announces a class action lawsuit has been initiated against Visa Inc. (NYSE: V). This legal action has garnered attention from investors seeking justice for losses incurred from their investments in Visa. Understanding the Allegations Against...

Continue Reading
How to Choose the Right Financial Advisor

Updated Category Personal Finance Views 14

Picking a financial advisor can feel a bit like shopping for a phone plan: every option sounds useful until the fees show up in tiny print. If you’re trying to grow your money, plan for retirement, or just stop second-guessing every investment move, understanding how advisors get paid matters more than most people realize. Once you know the compensation models, you can...

Continue Reading
Greenway Health Expands Leadership for Growth and Innovation

Updated Category News Views 312

Strategic Leadership Appointments at Greenway Health Greenway Health is making notable advancements in its Go-To-Market strategy by welcoming two experienced sales leaders to the team. This strategic move aims to boost customer acquisition and expand the company's presence in the healthcare technology sector. Introducing Geordie Sanborn, New Vice President of Sales...

Continue Reading